IMEXHS LIMITED — AGM Information 2021

May 12, 2021

==> picture [149 x 353] intentionally omitted <==

==> picture [45 x 86] intentionally omitted <==

Built by physicians for physicians Annual General Meeting

13 May 2021

1

Board of Directors

==> picture [132 x 157] intentionally omitted <==

==> picture [131 x 157] intentionally omitted <==

==> picture [131 x 157] intentionally omitted <==

Doug Flynn Carlos Palacio Dr Doug Lingard Non-Executive Non-Executive Non-Executive Chairman Director Director

==> picture [146 x 61] intentionally omitted <==

==> picture [132 x 157] intentionally omitted <==

==> picture [131 x 157] intentionally omitted <==

Damian Banks Non-Executive Director

Dr German Arango CEO and Managing Director

==> picture [349 x 25] intentionally omitted <==

2

Registration and Voting

==> picture [673 x 262] intentionally omitted <==

----- Start of picture text -----

2. Click view and register 3. Record your vote. Once
1. Log in or register at:
https://investor.automic.com.au/#/home your attendance for the you confirm it is lodged
meeting and final
----- End of picture text -----

To contact support: Call 1300 816 159 or open live chat from the Investor Portal

==> picture [172 x 20] intentionally omitted <==

==> picture [110 x 400] intentionally omitted <==

==> picture [135 x 48] intentionally omitted <==

Chairman’s Address Doug Flynn

4

==> picture [259 x 286] intentionally omitted <==

==> picture [146 x 61] intentionally omitted <==

Innovative provider of cloud-based medical imaging software solutions

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

5

==> picture [110 x 400] intentionally omitted <==

==> picture [135 x 48] intentionally omitted <==

CEO’s Address Dr German Arango

6

Democratise access to high tech imaging management platforms with advanced OUR PURPOSE clinical applications, user-friendly software and AI

OUR VALUE PROPOSITION

Patient-centric

Modern platform

Analytics

Clinical

collaboration

• Regional image exchange workflows

• Reduce IT infrastructure, system & administration

  • Multi-departmental business intelligence

• Shared workflows

• •

• Real-time exchanged • Dynamic Clinical intelligence

• • Multi-disciplinary networks presentation model • Live dashboards imaging •

• • Physicians & patients • Real-time • Predictive analysis Shared applications portals communications & • AI-enabled

• • 100% Web technology • Care coordination collaborations

  • Clinical intelligence

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

7

Expanding global footprint

==> picture [483 x 302] intentionally omitted <==

----- Start of picture text -----

Spain
USA
Mexico Honduras
El Salvador Nicaragua Australia
Costa Rica Colombia
Panama
Ecuador
Peru Brazil
Bolivia
Paraguay
Chile Uruguay
IMEXHS currently operating
Argentina
Agreement being negotiated
----- End of picture text -----

==> picture [146 x 61] intentionally omitted <==

15 countries

>270 sites

>2,100 radiologists

25 distributors

+95% customer retention

1/3 of team software development

8

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

Leading innovator in medical imaging

==> picture [146 x 61] intentionally omitted <==

• Multi-tenant architecture, cloudbased medical imaging software

• HIRUKO[TM] platform provides solutions for all complexity levels

• Subscription model with high recurring revenue from multi-year contracts

• Aquila in the Cloud standardised radiology solution

• Multiple distribution channels across 15 countries

• Developing AI tools - large proprietary database of 940m stored images

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

9

Multiple runways for growth

==> picture [146 x 61] intentionally omitted <==

Aquila Custom

Aquila in the Cloud

• •

• Aquila customised Standardised radiology offering radiology solution

• • 5-year contracts on • 1-2 year contracts on average average

• • • Subscription model Volume-based model

Other Medical Verticals

• Alula – pathology

• • Anteros – cardiology

• • Extend into other verticals

Expanding into new geographies including US

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

10

HIRUKO[TM] medical imaging platform

==> picture [146 x 61] intentionally omitted <==

==> picture [650 x 276] intentionally omitted <==

----- Start of picture text -----

Advanced Stella Vital Alma
Braviz
Post-processing AI 3D ADv 3D Basic
Enterprise Aquila Alula Anteros
Imaging Radiology Pathology Cardiology
HIRUKO [TM] Universal
Core Platform Portals Multi-Tenancy
PACS/VNA Viewer
Nuance 360
----- End of picture text -----

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

11

*Components in blue represent IMEXHS proprietary technology

==> picture [720 x 138] intentionally omitted <==

----- Start of picture text -----

End-to-end modular imaging solution
----- End of picture text -----

==> picture [707 x 240] intentionally omitted <==

----- Start of picture text -----

Scan scheduled Uploaded Archived on our 1)Business
Manages
via our to our platform cloud-based Intelligence
Billing
platform platform } 2)Statistical
Data
3. 4. 5.
1. 2. Radiologist Referring Physician Billing
Physician Patient has interprets scanned reviews images via (where
requests patient scheduled scan images Referring applicable)
scan ( Tele-Radiology [1] ) Physician Portal
1 Teleradiology - radiology concerned with the transmission of digitised medical images (as X-rays, CT scans, and sonograms) over electronic networks and with the interpretation of the
transmitted images for diagnostic purposes
----- End of picture text -----

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

12

Aquila in the Cloud

• Standardised radiology solution launched in May 2020

• Provides small and medium-sized customers with low-cost, rapidly deployed product offering

• At 31 March 2021, 60 deals signed with ARR contribution of $1.3m

• 3 deals in the USA and Australian customer undertaking 30-day trial

• Distribution via growing partner network and online marketplaces

• Strong pipeline of new opportunities

==> picture [146 x 61] intentionally omitted <==

==> picture [287 x 257] intentionally omitted <==

----- Start of picture text -----

$1,300k
60
$945k
$675k 41
$473k
$400k 28
17
12
Sept Oct Nov Dec Mar
New contracts (cumulative) ARR contribution
----- End of picture text -----

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

13

Range of solutions for AiC customers

==> picture [146 x 61] intentionally omitted <==

==> picture [578 x 276] intentionally omitted <==

----- Start of picture text -----

LITE PRO ULTIMATE
Multiplatform
Unlimited Users
Unlimited Exams
100% Web Platform Modality Worklist Scheduling
Management
VNA | PACS Archiving SMS notifications
Digital Signature in Reports
Web Viewer Patient Admission
VR Web (Reporting) ()
Results Distribution Questionnaire
Results Distribution
Standard KPIs Business Intelligence (BI)
Patient & Physician Portal
----- End of picture text -----*

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

14

==> picture [146 x 61] intentionally omitted <==

Multiple distribution channels

• Distributors partners represent important sales channel for both Aquila Custom and Aquila in the Cloud

• New distribution channel on Ingram’s Micro Cloud marketplace

==> picture [648 x 222] intentionally omitted <==

----- Start of picture text -----

DISTRIBUTION CHANNELS
DIRECT SALES DISTRIBUTORS
• Several markets • Agreements with distributor partners
• Global cloud marketplace • Low risk go-to-market strategy
Private Hospitals & Clinics Public Hospitals & Clinics Private Practices
----- End of picture text -----

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

15

Developing AI capabilities

==> picture [146 x 61] intentionally omitted <==

==> picture [627 x 216] intentionally omitted <==

----- Start of picture text -----

Number of Images Stored (m)
•
Images almost doubled to 940m reflecting
940
full year of Colsubsidio contract
•
Important test bed for the development
and training of AI tools
488
•
Developed Stella AI which identifies normal
and pathological radiological patterns in
231
chest x-rays
99
32
•
Released non-imaging AI tools in natural
language processing 2016 2017 2018 2019 2020
----- End of picture text -----

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

16

FY20 Financial Highlights

==> picture [146 x 61] intentionally omitted <==

Sales Revenue of $10.9m Up 41% yoy[1] , new contract wins & renewals Recurring revenue of $8.5m Up 29% yoy[2]

ARR of EBITDA of $10.1m ($1.3m) Up 19% yoy, 33% higher on a Improvement of $3.3m, constant currency basis $2.5m on like for like basis[3] Underlying EBITDA[4] of Closing cash of ($0.7m) $10.8m Improvement of $3.8m, $7.1m at 31 Dec 2019 $3.0m on a like for like basis[3]

1. Sales revenue up 59% on a constant currency basis 2. Recurring revenue up 45% on a constant currency basis

2. Adjusting for the impact of software capitalisation policy adopted in FY20

3. Refer Slide 20 of FY20 Investor Presentation for Underlying EBITDA reconciliation

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

17

Strong growth in ARR

==> picture [357 x 260] intentionally omitted <==

----- Start of picture text -----

20162017201820192020Mar-21 Annualised Recurring Revenue
12
10
8
6
4
2
0
2016 2017 2018 2019 2020 Mar-21
Spot Not Yet Billing Constant Currency Not Yet Billing
Constant currency basis assumes that historic results are converted at the 31 Mar-21 exchange rate. This removes the impact of
changes in currency rates and allows comparison of IMEXHS’s underlying operating performance.
A$ Millions
----- End of picture text -----

==> picture [146 x 61] intentionally omitted <==

• Q1 FY21 Annual Recurring Revenue (ARR) of $11.0m (Q1 FY20: $9.2m)

• 19 AiC contract wins in Q1 FY21 including two in USA and one in Australia

• AQUILA Radiology Information System (RIS) installed in 17 new sites

• Recent contract wins include Clinica Reina Lucia (Colombia) and Perfectech SA (Ecuador)

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

18

Q1 FY21 Financial Highlights

==> picture [146 x 61] intentionally omitted <==

Sales revenue[1] of $2.5m Up 9% pcp, up 17% on a constant currency basis

ARR of $11.0m Up 19% pcp, up 29% on a constant currency basis

Recurring revenue[1] of $2.2m Up 7% pcp, up 15% on a constant currency basis

Closing cash of $10.3m $10.8m at 31 Dec 2020

1. Unaudited financial information

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

19

2021 Product Roadmap

==> picture [62 x 62] intentionally omitted <==

==> picture [62 x 62] intentionally omitted <==

AQUILA 4.0 with new features and functions orientated to US and Australian markets

Alula Marketplace , the world’s first dedicated pathology marketplace workflow program

Democratising access to high-tech medical imaging platforms

==> picture [62 x 62] intentionally omitted <==

Other medical verticals

• Dental Imaging platform

• Veterinary Information System

==> picture [146 x 61] intentionally omitted <==

==> picture [62 x 62] intentionally omitted <==

AI Algorithms

• Automatic detection and segmentation of infectious lung disease

• • Automatic selection of protocols requiring advance postprocessing and rendering of functional MRI and DTI tractography

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

20

2021 Outlook

Strong near-term pipeline for larger customised solutions

Aquila in the Cloud (AiC) – strong underlying demand as optimise preinstallation activities Partner program continues to create opportunities in new markets

==> picture [146 x 61] intentionally omitted <==

US – build presence with AiC offering and via online marketplaces

New markets – delay in Brazil due to COVID-19

Trading to date in line with Company expectations for 2021

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

21

==> picture [149 x 353] intentionally omitted <==

==> picture [45 x 86] intentionally omitted <==

Built by physicians for physicians

2021 Annual General Meeting BUSINESS OF MEETING

22

==> picture [146 x 61] intentionally omitted <==

2020 Financial Statement and Reports

To receive the financial report of the Company and the reports of the Directors and of the Auditors for the financial year ended 31 December 2020.

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

23

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 1: Remuneration Report

“The Remuneration Report for the financial year ended 31 December 2020 as disclosed in the Company’s Annual Report be adopted.”

FOR	AGAINST	OPEN
6,842,254	1	152,208
97.82%	0%	2.18%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

24

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 2: Re-election of Director – Mr Damian Banks

“That, for the purpose of Article 6.3(j) of the Constitution, ASX Listing Rule 14.4 and for all other purposes, Mr Damian Banks, a Director having been appointed by the Board, retires, and being eligible, is re-elected as a Director of the Company.”

FOR	AGAINST	OPEN
13,566,085	-	152,208
98.89%	-	1.11%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

25

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 3: Re-election of Director – Dr Douglas Lingard “That, for the purpose of Article 6.3(c) of the Constitution, ASX Listing Rule 14.4, and for all other purposes, Dr Douglas Lingard, a Director, retires by rotation, and being eligible, is re-elected as a Director of the Company.”

FOR	AGAINST	OPEN
13,350,292	45,793	152,208
98.54%	0.34%	1.12%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

26

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 4: Grant of Options to the Chief Executive Officer “That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 43,519 Options to the Managing Director & CEO, Dr German Arango, under the Plan on the terms and conditions set out in the Explanatory Statement.”

FOR	AGAINST	OPEN
6,842,255	1	152,207
97.82%	0%	2.18%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

27

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 5: Grant of Options to Non-Executive Director, Mr Damian Banks

“That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 19,719 Options to Non-Executive Director, Mr Damian Banks, under the Plan on the terms and conditions set out in the Explanatory Statement.”

FOR	AGAINST	OPEN
6,842,255	1	152,207
97.82%	0%	2.18%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

28

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 6: Grant of Options to Non-Executive Director, Mr Douglas Flynn

“That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 39,437 Options to Non-Executive Director, Mr Douglas Flynn, under the Plan on the terms and conditions set out in the Explanatory Statement.”

FOR	AGAINST	OPEN
6,842,255	1	152,207
97.82%	0%	2.18%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

29

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 7: Grant of Options to Non-Executive Director, Dr Douglas Lingard

“That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 19,719 Options to Non-Executive Director, Dr Doug Lingard, under the Plan on the terms and conditions set out in the Explanatory Statement.”

FOR	AGAINST	OPEN
6,796,462	45,794	152,207
97.17%	0.65%	2.18%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

30

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 8: Grant of Options to Non-Executive Director, Mr Carlos Palacio

“That, for the purposes of ASX Listing Rule 10.14 and all other purposes, the Shareholders approve the grant of 19,719 Options to Non-Executive Director, Mr Carlos Palacio, under the Plan on the terms and conditions set out in the Explanatory Statement.”

FOR	AGAINST	OPEN
6,842,255	1	152,207
97.82%	0%	2.18%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

31

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 9: Approval of 10% Share Placement Capacity "That, for the purposes of ASX Listing Rule 7.1A and for all other purposes, Shareholders approve the Company having additional capacity to issue Equity Securities up to 10% of the issued capital of the Company (at the time of the issue) (10% Share Placement Capacity) calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 and on the terms and conditions set out in the Explanatory Statement.”

FOR	AGAINST	OPEN
13,566,085	-	152,208
98.89%	-	1.11%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

32

==> picture [146 x 61] intentionally omitted <==

RESOLUTION 10: Ratification of Prior Issue of Securities (Placement) “That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, the Shareholders ratify the issue on 30 October 2020 of a total of 276,000,000 fully paid ordinary shares in the Company at an issue price of $0.03 per share, on the terms and conditions set out in the Explanatory Memorandum.”

FOR	AGAINST	OPEN
9,123,717	-	152,208
98.36%	-	1.64%

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING MAY 2021

33

Disclaimer

==> picture [146 x 61] intentionally omitted <==

The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipient on the terms and conditions set out in this notice.

The Recipient should not treat the Information as advice relating to legal, taxation, financial product or investment matters and should consult their own advisers. This Presentation does not purport to contain all the information that a prospective investor may require. The Information may not be appropriate for all persons and it is not possible for ImExHS Limited to have regard to the investment objectives, financial situation and particular needs of each Recipient who reads or uses the Information . Accordingly, no recommendation or expression of opinion is contained within the Information. Further, no representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the Information, including the likelihood of achievement or reasonableness or any forecasts, prospects or returns contained in the Information. Before acting in reliance on any Information, the Recipient should conduct their own investigation and analysis in relation to the investment opportunity presented by this Presentation and should check the accuracy, reliability and completeness of the Information and obtain independent and specific advice from appropriate professional advisers. Statements contained in the Information, particularly those regarding possible or assumed future performance or potential growth, prospects or projections of ImExHS Limited are, or may be, forward looking statements. Such statements relate to future events and expectations and, as such, involve known and unknown risks, uncertainties and contingencies. The Information may also be subject to clarification and change and ImExHS Limited may in its absolute discretion, but without being under any obligation to do so, update, amend or supplement the Information.

The Information is for informational purposes only and does not constitute an offer to issue, or arrange to issue, securities or other financial products. The Information is not, and should not be construed to be, a Prospectus.

To the maximum extent permitted by law none of ImExHS Limited or its respective employees, agents or consultants nor any other person accepts any liability, including, without limitation, any liability arising out of fault of negligence, for any loss arising from the use of the Information.

IMEXHS LTD (ASX:IME) | ANNUAL GENERAL MEETING

34